Kevin Kris Warnakula Olesen

Net clinical benefit of #DPI with low-dose #rivaroxaban consistently observed in CAD patients at low, moderate or high CV risk: Data from the COMPASS trial in #EHJPharmacotherapy 👉 bit.ly/3TKFztf @DLBHATTMD @mirvatalasnag @FeliceGragnano @EditorEHJCVP

🫀New publication in @JACCJournals by @CGyldenkerne et al. 👩‍🎓 Young patients with newly diagnosed #type2diabetes have the highest relative risk of #CVD 📷 Indicate an unmet need for optimized prophylactic treatment! @MichaelMaeng1 @dr_rwt link: jacc.org/doi/abs/10.101…

Patienter med akut blodprop i hjertet, der overlever de første 90 dage, har ingen overdødelighed sammenlignet med den øvrige befolkning, viser dansk undersøgelse præsenteret på #ESCCongress2023 #sundpol buff.ly/47TncqM

CONGRATULATIONS TO OUR NEW SCIENCE AMBASSADORS 2023🤩📷Together with @gunngis from the @Hjerteforening we had the privilege of appointing 20 new science ambassadors this Wednesday. We wish the young researchers good luck on their research journey. @novonordisk

#Statins but NOT #aspirin reduced CV risk in #diabetes patients without obstructive CAD: new observational evidence from a large 🇩🇰 study 💊⤵️ academic.oup.com/ehjcvp/article… #EHJPharmacotherapy @AgewallStefan #CardioTwitter #ESCYoung @escardio @ESC_Journals @KrisWarnakula @MichaelMaeng1

At #ESCCongress @KrisWarnakula just presented a large study examining wether diabetes remains a cardiovascular risk equivalent to #CHD @escardio #ESC2022 Watch this clip for the main results 👇🏻

Read our newest study in @EJCI_News!🎉 onlinelibrary.wiley.com/doi/10.1111/ec… Guideline implementation of the CHA2DS2-VASC score was associated with increased use of triple therapy and a decline in ischemic outcomes. Paradoxically, risk of bleeding remained constant @AUHCardio @michael_maeng

PhD student @GroThrane presented her study on #Ticagrelor implementation in PCI-treated #ACS patients at #ESCCongress 💊 Watch on demand 👉 cyim.page.link/JCHv @escardio #CardioTwitter

At the session Latest science in CV prevention at #ESCCongress, PhD student Christine Gyldenkerne presented her study "Nationwide trends in stroke and #AF in patients with incident DM2" 🫀🧠 Watch on demand 👉 cyim.page.link/jUJ9 @escardio @dceaarhus #CardioTwitter

Watch the presentation on refining dual antithrombotic treatment in patients with #CCS by @KrisWarnakula at the session Latest Science in ACS #ESCCongress 🫀 👉 cyim.page.link/PDCj @escardio #CardioTwitter

A study from the Western Denmark Heart Registry by @KrisWarnakula et al., demonstrates that #diabetes increases the risk of limb amputations 🦵 by 5.5-fold in patients without coronary artery disease. Continued risk management is needed! drc.bmj.com/content/9/1/e0…

In this study by @KrisWarnakula et al., myocardial infarction🫀, ischemic stroke🧠, and cardiac death ⬇️ by up to 62% in patients with chronic coronary syndrome from 2004 to 2016. Likely caused by major improvements in treatment of CAD💊💉 academic.oup.com/ehjqcco/advanc…

In this study, @KrisWarnakula et al. found, that diabetes ptts without CAD have the same low 10-year risk of MI as the general population. However, they remain at increased risk of ischemic stroke and death 🧠⚰️ Still room for improvement! rdcu.be/cgWaL

Real-world data on the temporal trend in 2-yr CV risk of patients with chronic coronary syndrome and angiographic #CAD: we're on the right path! academic.oup.com/ehjqcco/advanc… #EHJQCCO #cardiotwitter #MI @adamtimmis @diogoasantosfer